ABSTRACT
The charge exchange recombination spectroscopy (CXRS) diagnostics on the T-10 tokamak is described. The system is based on a diagnostic neutral beam and includes three high etendue spectrometers designed for the ITER edge CXRS system. A combined two-channel spectrometer is developed for simultaneous measurements of two beam-induced spectral lines using the same lines of sight. A basic element of the combined spectrometer is a transmitting holographic grating designed for the narrow spectral region 5291 ± 100 Å. The whole CXRS system provides simultaneous measurements of two CXRS impurity spectra and Hα beam line. Ion temperature measurements are routinely provided using the C(6+) CXRS spectral line 5291 Å. Simultaneous measurements of carbon densities and one more impurity (oxygen, helium, lithium etc.) are carried out. Two light collecting systems with 9 lines of sight in each system are used in the diagnostics. Spatial resolution is up to 2.5 cm and temporal resolution of 1 ms is defined by the diagnostic neutral beam diameter and pulse duration, respectively. Experimental results are shown to demonstrate a wide range of the CXRS diagnostic capabilities on T-10 for investigation of impurity transport processes in tokamak plasma. Developed diagnostics provides necessary experimental data for studying of plasma electric fields, heat and particle transport processes, and for investigation of geodesic acoustic modes.
ABSTRACT
To examine risk factors and to design prognostic models for the total, relapse-free and after-relapse survival, use was made of the Cox model for unifactorial and multidimensional analysis based on the retrospective estimation of the results of the treatment of 235 patients with lymphogranulomatosis, stages II-III. Radiotherapy according to the radical program was carried out in conjunction with polychemotherapy according to the COPP scheme. The number of areas of damage, massiveness of injury to the mediastinum, involvement of the spleen into the process appeared the most informative risk factors for predicting both total and relapse-free survival. The prediction of the after-relapse survival was considerably influenced by the age combined with carrying out of not less than 3 cycles of polychemotherapy given to the patients during initial treatment or with the presence of intoxication symptoms and increased ESR. The tables of the survival probability were calculated.
